Presentation – Biological biomarkers

Biological Biomarkers in Multiple Sclerosis by Prof Irina Elovaara and Nikolaos C Grigoriadis.

October 2018, Biological Biomarkers in Multiple Sclerosis by Prof Irina Elovaara and Nikolaos C Grigoriadis.

ABSTRACT
Need for biomarkers in MS:
• New therapeutic agents with variable mechanisms of action are available
• The complexity and heterogeneity of MS urges a more differentiated
defining of patients
• Personalized therapy: the information on disease and molecular biomarker profile of a particular patient will contribute to better understanding of their disease, diagnosis and factors that determine response to therapy

IRINA ELOVAARA
MD, PhD Neuroimmunology Unit, University of Tampere &
Department of Neurology, Tampere University Hospital, Finland

NIKOLAOS GRIGORIADIS
MD, PhD Laboratory of Experimental Neurology and Neuroimmunology & Department of Neurology AHEPA University Hospital, Aristotle University of Thessaloniki, Greece




Media

Details

  • Directors

    ParadigMS
  • Author(s)

    Prof Irina Elovaara & Prof Nikolaos Grigoriadis
  • Country

    Belgium
  • Release Date

    October 15, 2018
  • Views


You Might Also Like

Article – Microbiome in Multiple Sclerosis

Private: Publication – ParadigMS 5th Symposium: Biological Biomarkers in Multiple Sclerosis

Webinar – An update in MS pathology and immunology


Subscribe to our bi-annual Newsletter

ParadigMS does not send eNewsletters that contain advertisements and we do not share your contact details with sponsors (unless we received your explicit consent)